Xenon Pharmaceuticals - Stock Price History | XENE
Historical daily share price chart and data for Xenon Pharmaceuticals since 2023 adjusted for splits. The latest closing stock price for Xenon Pharmaceuticals as of January 31, 2023 is 39.09.
- The all-time high Xenon Pharmaceuticals stock closing price was 39.82 on August 24, 2022.
- The Xenon Pharmaceuticals 52-week high stock price is 41.39, which is 5.9% above the current share price.
- The Xenon Pharmaceuticals 52-week low stock price is 24.94, which is 36.2% below the current share price.
- The average Xenon Pharmaceuticals stock price for the last 52 weeks is 33.86.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Xenon Pharmaceuticals Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2022 |
33.1731 |
31.5900 |
39.8200 |
25.0900 |
39.4300 |
26.22% |
| 2021 |
20.7130 |
14.7400 |
35.4000 |
13.6500 |
31.2400 |
103.12% |
| 2020 |
12.5954 |
13.7200 |
17.5700 |
8.0800 |
15.3800 |
17.32% |
| 2019 |
9.5171 |
6.6800 |
14.6500 |
6.3900 |
13.1100 |
107.77% |
| 2018 |
7.6217 |
2.8750 |
14.9000 |
2.7000 |
6.3100 |
123.36% |
| 2017 |
4.3814 |
7.8500 |
9.8500 |
2.2000 |
2.8250 |
-63.31% |
| 2016 |
7.4501 |
7.9600 |
8.5500 |
5.8800 |
7.7000 |
-4.23% |
| 2015 |
12.6255 |
18.7000 |
23.0000 |
7.6900 |
8.0400 |
-59.29% |
| 2014 |
14.6806 |
10.5000 |
19.9100 |
10.5000 |
19.7500 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.377B |
$0.018B |
|
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan as well as more prevalent diseases. The company offers Glybera (R), a gene therapy for the treatment of lipoprotein lipase deficiency, an orphan disorder. Xenon Pharmaceuticals Inc. is headquartered in Burnaby, Canada.
|
